Predictors of Survival After a Diagnosis of Non-Hodgkin Lymphoma in a Resource-Limited Setting: A Retrospective Study on the Impact of HIV Infection and Its Treatment
- 1 April 2011
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 56 (4) , 312-319
Abstract
Objective: We examined factors associated with survival among patients with newly diagnosed non-Hodgkin lymphoma (NHL) in Uganda. Methods: Information was abstracted from medical records for all NHL patients >13 years of age at the Uganda Cancer Institute between January 2004 and August 2008. Cox proportional hazard models were used to identify predictors of NHL survival. Results: One hundred sixty patients with NHL were identified; 51 (31.9%) were known to be HIV positive. Overall, 154 patients had records sufficient for further analysis. The median person-time observed was 104 days (interquartile range 26-222). Median survival after presentation among those whose mortality status was confirmed was 61 days (interquartile range 25-203). HIV-positive patients receiving antiretroviral therapy had survival rates approximating those of HIV-negative persons, but the adjusted hazard of death was significantly elevated among HIV-positive patients not receiving antiretroviral therapy [adjusted hazard ratio (HR) 8.99, P < 0.001] compared with HIV-negative patients. Both B-symptoms (HR 2.08, P = 0.05) and female gender (HR 1.72, P = 0.05) were associated with higher mortality. Conclusions: In Uganda, overall survival of NHL patients is poor, and predictors of survival differed from those described in resource-rich regions. HIV is a common comorbidity to NHL, and its lack of treatment was among the strongest predictors of mortality. Strategies are needed for optimal management of HIV-infected individuals with cancer in resource-limited settings.Keywords
This publication has 42 references indexed in Scilit:
- Quality of life, characteristics and survival of patients with HIV and lymphomaQuality of Life Research, 2010
- Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, UgandaBMC Clinical Pathology, 2009
- Clinical characteristics and outcome of children with Burkitt lymphoma in Uganda according to HIV infectionPediatric Blood & Cancer, 2008
- Malignant lymphomas (ML) and HIV infection in TanzaniaJournal of Experimental & Clinical Cancer Research, 2008
- The spectrum of human immunodeficiency virus‐associated cancers in a South African black population: Results from a case–control study, 1995–2004International Journal of Cancer, 2008
- Former African Cancer Research Powerhouse Makes Plans for a Return to GreatnessJNCI: Journal of the National Cancer Institute, 2007
- The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOPBlood, 2006
- Improved survival and chemotherapy response among patients with AIDS‐related non‐Hodgkin's lymphoma receiving highly active antiretroviral therapyHematological Oncology, 2006
- AIDS-Related Burkitt's Lymphoma Versus Diffuse Large-Cell Lymphoma in the Pre–Highly Active Antiretroviral Therapy (HAART) and HAART Eras: Significant Differences in Survival With Standard ChemotherapyJournal of Clinical Oncology, 2005
- RituximabDrugs, 2003